Emerald Advisers’s AtriCure ATRC Stock Holding History

Emerald Advisers’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-89,098	Closed	-$2.72M	–	246
2024 Q4	$2.72M	Sell	89,098 -300,738	-77%	-$9.67M	0.11%	119
2024 Q3	$10.9M	Buy	389,836 +38,421	+11%	+$947K	0.42%	82
2024 Q2	$8M	Sell	351,415 -99,843	-22%	-$2.3M	0.34%	97
2024 Q1	$13.7M	Buy	451,258 +4,978	+1%	+$167K	0.55%	73
2023 Q4	$15.9M	Sell	446,280 -52,692	-11%	-$1.96M	0.68%	61
2023 Q3	$21.9M	Buy	498,972 +3	+0%	+$146	1.06%	31
2023 Q2	$24.6M	Sell	498,969 -8,889	-2%	-$410K	1.08%	33
2023 Q1	$21.1M	Sell	507,858 -9,259	-2%	-$384K	1.01%	36
2022 Q4	$22.9M	Buy	517,117 +88,486	+21%	+$3.7M	1.11%	31
2022 Q3	$16.8M	Buy	428,631 +200	+0%	+$9.15K	0.86%	49
2022 Q2	$17.5M	Sell	428,431 -7,948	-2%	-$376K	0.9%	40
2022 Q1	$28.7M	Buy	436,379 +40,816	+10%	+$2.64M	1.09%	29
2021 Q4	$27.5M	Sell	395,563 -8,426	-2%	-$612K	1.02%	36
2021 Q3	$28.1M	Sell	403,989 -93,040	-19%	-$7.16M	1.02%	33
2021 Q2	$39.4M	Sell	497,029 -4,282	-0.9%	-$311K	1.44%	13
2021 Q1	$32.8M	Sell	501,311 -34,788	-6%	-$2.14M	1.19%	19
2020 Q4	$29.8M	Buy	536,099 +35,251	+7%	+$1.52M	0.99%	32
2020 Q3	$20M	Sell	500,848 -21,425	-4%	-$909K	0.82%	49
2020 Q2	$23.5M	Buy	522,273 +95,661	+22%	+$4.16M	1.02%	36
2020 Q1	$14.3M	Sell	426,612 -1,907	-0.4%	-$68.6K	0.83%	44
2019 Q4	$13.9M	Sell	428,519 -11,492	-3%	-$327K	0.59%	71
2019 Q3	$11M	Sell	440,011 -33,219	-7%	-$948K	0.51%	79
2019 Q2	$14.1M	Sell	473,230 -4,600	-1%	-$134K	0.57%	76
2019 Q1	$12.8M	Buy	477,830 +10,720	+2%	+$326K	0.52%	76
2018 Q4	$14.3M	Sell	467,110 -11,586	-2%	-$361K	0.7%	56
2018 Q3	$16.8M	Sell	478,696 -19,890	-4%	-$630K	0.62%	77
2018 Q2	$13.5M	Sell	498,586 -5,410	-1%	-$127K	0.51%	92
2018 Q1	$10.3M	Sell	503,996 -49,415	-9%	-$892K	0.41%	100
2017 Q4	$10.1M	Sell	553,411 -7,290	-1%	-$144K	0.39%	100
2017 Q3	$12.5M	Buy	560,701 +13,940	+3%	+$315K	0.51%	80
2017 Q2	$13.3M	Sell	546,761 -29,756	-5%	-$633K	0.55%	75
2017 Q1	$11M	Sell	576,517 -7,220	-1%	-$126K	0.45%	88
2016 Q4	$11.4M	Buy	583,737 +122,304	+27%	+$2.22M	0.49%	83
2016 Q3	$7.3M	Sell	461,433 -30,760	-6%	-$473K	0.33%	109
2016 Q2	$6.96M	Sell	492,193 -307,328	-38%	-$4.68M	0.34%	106
2016 Q1	$13.5M	Buy	799,521 +4,417	+0.6%	+$77.7K	0.66%	56
2015 Q4	$17.8M	Buy	795,104 +183,065	+30%	+$3.77M	0.84%	30
2015 Q3	$13.4M	Buy	612,039 +50,391	+9%	+$1.26M	0.7%	43
2015 Q2	$13.8M	Buy	561,648 +194,462	+53%	+$4.34M	0.66%	50
2015 Q1	$7.51M	Buy	367,186 +69,360	+23%	+$1.34M	0.38%	86
2014 Q4	$5.95M	Buy	297,826 +62,666	+27%	+$1.08M	0.32%	105
2014 Q3	$3.46M	Buy	235,160 +41,880	+22%	+$667K	0.21%	150
2014 Q2	$3.55M	Buy	193,280 +60,060	+45%	+$1,000K	0.2%	155
2014 Q1	$2.51M	Buy	+133,220	New	+$2.73M	0.14%	177

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Emerald Advisers's ATRC Position: Q1 2025 in Review

Emerald Advisers sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 89,098 shares — an estimated $2.72M sold.

Emerald Advisers first reported a position in ATRC in Q1 2014 and held it in 44 quarters. The position peaked at $39.4M in Q2 2021. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

Emerald Advisers reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
Emerald Advisers sold 89,098 AtriCure shares in Q1 2025, an estimated $2.72M.
Emerald Advisers first reported a position in AtriCure in Q1 2014 and held it in 44 quarters.
Emerald Advisers's AtriCure position peaked at $39.4M in Q2 2021.
221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Emerald Advisers's 13F filing for Q1 2025, filed 1 May 2025.